• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

诱导治疗的作用：诱导治疗后的非小细胞肺癌的手术切除。

Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy.

机构信息

Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

出版信息

Thorac Surg Clin. 2013 Aug;23(3):273-85. doi: 10.1016/j.thorsurg.2013.04.004. Epub 2013 May 17.

DOI:10.1016/j.thorsurg.2013.04.004
PMID:23931012
Abstract

Patients with Stage III non-small cell lung cancer are best managed by multimodality therapy. Patients with N2 disease can be treated with induction therapy (usually chemotherapy) followed by surgical resection. Patients whose medical comorbidities preclude surgery should be treated with definitive chemoradiotherapy. T3 or T4 tumors involving the superior sulcus or spine are best managed with induction chemoradiotherapy and surgical resection.

摘要

III 期非小细胞肺癌患者最好采用多模式治疗。N2 期疾病患者可采用诱导治疗（通常为化疗）后行手术切除。因合并症而不能手术的患者应采用根治性放化疗。累及上纵隔或脊柱的 T3 或 T4 肿瘤最好采用诱导放化疗和手术切除。

相似文献

1
Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy.诱导治疗的作用：诱导治疗后的非小细胞肺癌的手术切除。
Thorac Surg Clin. 2013 Aug;23(3):273-85. doi: 10.1016/j.thorsurg.2013.04.004. Epub 2013 May 17.
2
Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?手术是否应成为 IIIB 期非小细胞肺癌多模式治疗的一部分？
J Surg Oncol. 2018 Jun;117(7):1570-1574. doi: 10.1002/jso.25042. Epub 2018 Mar 24.
3
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).诱导化疗和同期放化疗后可切除 IIIA(N2)和部分 IIIB 期非小细胞肺癌患者的手术与根治性同期放化疗增敏的 III 期研究（ESPATUE）
J Clin Oncol. 2015 Dec 10;33(35):4194-201. doi: 10.1200/JCO.2015.62.6812. Epub 2015 Nov 2.
4
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.诱导化疗联合放化疗治疗 IIIA/N2 期非小细胞肺癌：一项 3 期随机试验。
Lancet. 2015 Sep 12;386(9998):1049-56. doi: 10.1016/S0140-6736(15)60294-X. Epub 2015 Aug 11.
5
Keys to successful induction chemoradiotherapy followed by surgery for stage III/N2 non-small cell lung cancer.成功诱导放化疗序贯手术治疗 III/N2 期非小细胞肺癌的关键因素。
Surg Today. 2019 Jul;49(7):547-555. doi: 10.1007/s00595-019-1766-8. Epub 2019 Feb 18.
6
Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?肺切除术：在 III 期非小细胞肺癌的三联疗法中可计算或不可耐受的风险因素？
Eur J Cardiothorac Surg. 2012 Apr;41(4):880-5; discussion 885. doi: 10.1093/ejcts/ezr160. Epub 2012 Jan 10.
7
Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.两种常用于局部晚期III期非小细胞肺癌的新辅助放化疗方案：长期结果及与病理反应的关联
J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13. doi: 10.1016/j.jtcvs.2003.07.027.
8
Anatomical lung resection after neoadjuvant chemoradiotherapy.新辅助放化疗后的肺解剖切除术。
Semin Thorac Cardiovasc Surg. 2007 Winter;19(4):360-5. doi: 10.1053/j.semtcvs.2007.12.002.
9
Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer.诱导放化疗并不优于 IIIA 期肺癌的单纯诱导化疗。
Ann Thorac Surg. 2012 Jun;93(6):1807-12. doi: 10.1016/j.athoracsur.2012.03.018.
10
Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.N2期非小细胞肺癌新辅助同步放化疗后手术的疗效
Lung Cancer. 2016 Jun;96:56-62. doi: 10.1016/j.lungcan.2016.03.016. Epub 2016 Mar 29.

引用本文的文献

1
Major pulmonary resection after neoadjuvant chemotherapy or chemoradiation in potentially resectable stage III non-small cell lung carcinoma.新辅助化疗或放化疗后潜在可切除的 III 期非小细胞肺癌的大肺切除术。
Sci Rep. 2021 Oct 12;11(1):20232. doi: 10.1038/s41598-021-99271-3.
2
[Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review].[支气管覆膜支架封堵术治疗右中下肺叶切除术后支气管残端瘘：病例报告及文献复习]
Zhongguo Fei Ai Za Zhi. 2021 Apr 20;24(4):299-304. doi: 10.3779/j.issn.1009-3419.2021.101.11.
3
Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment.
可切除的IIIA-N2期非小细胞肺癌（NSCLC）：探寻合适的治疗方法。
Cancers (Basel). 2020 Jul 25;12(8):2050. doi: 10.3390/cancers12082050.
4
Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?诱导治疗会增加支气管袖状切除术中的吻合口并发症吗？
World J Surg. 2019 May;43(5):1385-1392. doi: 10.1007/s00268-019-04908-0.
5
Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.手术切除的 ypN2 期非小细胞肺癌的术后放疗。
Ann Thorac Surg. 2018 Sep;106(3):848-855. doi: 10.1016/j.athoracsur.2018.04.064. Epub 2018 May 26.
6
Distinct patterns of angiogenic factor expression as a predictive factor of response to chemotherapy in stage IIIA non-small-cell lung cancer patients.血管生成因子表达的不同模式作为IIIA期非小细胞肺癌患者化疗反应的预测因素
Mol Clin Oncol. 2016 Oct;5(4):440-446. doi: 10.3892/mco.2016.966. Epub 2016 Jul 27.
7
Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer.诱导后正电子发射断层扫描对ⅢA期非小细胞肺癌N2淋巴结的评估与ypN2疾病或总生存期无关。
J Thorac Cardiovasc Surg. 2016 Apr;151(4):969-77, 979.e1-3. doi: 10.1016/j.jtcvs.2015.09.127. Epub 2015 Oct 19.
8
Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.在诱导化疗基础上加用放疗并不能提高可手术切除的临床N2期非小细胞肺癌患者的生存率。
J Thorac Cardiovasc Surg. 2015 Dec;150(6):1484-92; discussion 1492-3. doi: 10.1016/j.jtcvs.2015.06.062. Epub 2015 Jul 2.
9
Surgical strategies in the therapy of non-small cell lung cancer.非小细胞肺癌治疗中的手术策略
World J Clin Oncol. 2014 Oct 10;5(4):595-603. doi: 10.5306/wjco.v5.i4.595.
10
Surgery in 2013 and beyond.2013年及以后的外科手术。
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S593-606. doi: 10.3978/j.issn.2072-1439.2013.07.39.